510(k) K211685

Elecsys Testosterone II by Roche Diagnostics — Product Code CDZ

K211685 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys Testosterone II". The FDA issued a decision of Substantially Equivalent on May 6, 2022. The device falls under product code CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone), a Class I device regulated under 21 CFR 862.1680. Roche Diagnostics has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 6, 2022
Date Received
June 2, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class
Class I
Regulation Number
862.1680
Review Panel
CH
Submission Type